Literature DB >> 1609782

HLA-DR2 predicts a favorable response to cyclosporine therapy in patients with bone marrow failure.

S Nakao, M Yamaguchi, M Saito, S Yasue, S Shiobara, T Matsuda, M Nitta, M Sasaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1609782     DOI： 10.1002/ajh.2830400319

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  6 in total

Review 1.  Genetics of graft-versus-host disease: the major histocompatibility complex.

Authors:  Effie W Petersdorf
Journal:  Blood Rev       Date:  2012-11-20       Impact factor: 8.250

2.  HLA-matched sibling transplantation for severe aplastic anemia: impact of HLA DR15 antigen status on engraftment, graft-versus-host disease, and overall survival.

Authors:  Minoo Battiwalla; Tao Wang; Jeanette Carreras; H Joachim Deeg; Mouhab Ayas; Rajinder P S Bajwa; Biju George; Vikas Gupta; Ricardo Pasquini; Hubert Schrezenmeier; Jakob R Passweg; Kirk R Schultz; Mary Eapen
Journal:  Biol Blood Marrow Transplant       Date:  2012-02-28       Impact factor: 5.742

3.  HLA DR15 antigen status does not impact graft-versus-host disease or survival in HLA-matched sibling transplantation for hematologic malignancies.

Authors:  Minoo Battiwalla; Kristin Ellis; Peigang Li; Steven Z Pavletic; Gorgun Akpek; Peiman Hematti; Thomas R Klumpp; Richard T Maziarz; Bipin N Savani; Mahmoud D Aljurf; Mitchell S Cairo; William R Drobyski; Biju George; Theresa Hahn; Nandita Khera; Mark R Litzow; Alison W Loren; Wael Saber; Mukta Arora; Alvaro Urbano-Ispizua; Corey Cutler; Mary E D Flowers; Stephen R Spellman
Journal:  Biol Blood Marrow Transplant       Date:  2012-03-10       Impact factor: 5.742

4.  HLA-DR2 Frequency Increase in Severe Aplastic Anemia Patients is Mainly Attributed to the Prevalence of DR15 Subtype.

Authors:  Sergey I Kapustin; Tamara I Popova; Anton A Lyschov; Alexander V Togo; Kudrat M Abdulkadyrov; Michail N Blinov
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

5.  Successful treatment using tacrolimus plus corticosteroid in a patient with RA associated with MDS.

Authors:  Yuji Nozaki; Yasuaki Nagare; Koji Kinoshita; Fumiaki Urase; Masanori Funauchi
Journal:  Rheumatol Int       Date:  2007-08-29       Impact factor: 2.631

6.  Correlation analysis of severe aplastic anemia immunosuppressive therapy and human leukocyte antigen alleles in pediatric patients.

Authors:  Ru-Ting Fu; Hong-Man Xue; Bi-Hong Zhang; Jian Wang; Shao-Fen Lin; Chun Chen
Journal:  Exp Ther Med       Date:  2015-10-15       Impact factor: 2.447
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.